Lipocine
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $89 | $7,617 | $216 |
Gross Profit | -1,785 | 7,617 | 216 | |
EBITDA | -2,621 | -3,284 | 3,231 | -2,273 |
EBIT | -2,630 | -3,292 | 3,222 | -2,281 |
Net Income | -2,218 | -3,068 | 3,513 | -2,282 |
Net Change In Cash | 0 | 89 | 7,617 | 216 |
Free Cash Flow | 10 | -2,497 | 2,407 | -2,031 |
Cash | 3,742 | 5,553 | 3,081 | 4,771 |
Basic Shares | 5,347 | 5,343 | 5,357 | 5,316 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $-2,850 | $500 | $16,140 | $ |
Gross Profit | -2,850 | 500 | 16,140 | -9,748 |
EBITDA | -16,322 | -10,721 | -430 | -17,992 |
EBIT | -16,351 | -10,730 | -430 | -17,996 |
Net Income | -16,352 | -10,758 | -634 | -20,964 |
Net Change In Cash | -2,850 | 500 | 16,140 | |
Cost of Revenue | -21,266 | 9,488 | ||
Free Cash Flow | -11,879 | -12,102 | -4,418 | -15,303 |
Cash | 4,771 | 3,148 | 2,950 | 19,217 |
Basic Shares | 5,269 | 5,256 | 5,154 | 3,275 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.41 |
2024-06-30 | -$0.57 |
2024-03-31 | $0.66 |
2023-12-31 | -$0.42 |
